Carrier systems and application of growth factors in orthopaedics (Q37274336)

19 August 2017

1 reference

title

Carrier systems and application of growth factors in orthopaedics (English)

1 reference

19 August 2017

Britt Wildemann

4

0 references

author name string

Gerhard Schmidmaier

series ordinal

1

1 reference

PubMed ID

18804572

19 August 2017

Philipp Schwabe

series ordinal

2

1 reference

PubMed ID

18804572

19 August 2017

Catrin Strobel

series ordinal

3

1 reference

19 August 2017

1 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

39 Suppl 2

1 reference

19 August 2017

S37-43

1 reference

Fracture healing: the diamond concept

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Use of bone morphogenetic proteins for treatment of non-unions and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Biological enhancement of bone healing with Bone Morphogenetic Protein-7 at the clinical setting of pelvic girdle non-unions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

The health economics of the treatment of long-bone non-unions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Therapeutic outcome in tibial pseudarthrosis: bone morphogenetic protein 7 (BMP-7) versus autologous bone grafting for tibial fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Recombinant human bone morphogenetic protein induces bone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Osteoinductive implants: the mise-en-scène for drug-bearing biomimetic coatings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Delivery of bone morphogenetic proteins for orthopedic tissue regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Bone substitutes: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Polylactic acid for surgical implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Biodegradable poly(lactic acid) polymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Erosion kinetics of hydrolytically degradable polymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Immuno-inflammatory tissue reaction to stainless-steel and titanium plates used for internal fixation of long bones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Absorbable intramedullary implants for hand fractures. Animal experiments and clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating maintain their activity over long-term storage-cell culture studies on primary human osteoblast-like cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Insulin-like growth factor-1 and transforming growth factor-beta1 accelerates osteotomy healing using polylactide-coated implants as a delivery system: a biomechanical and histological study in minipigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Local delivery of growth factors from coated titanium plates increases osteotomy healing in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers, PCNA and BrdU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Quantification, localization, and expression of IGF-I and TGF-beta1 during growth factor-stimulated fracture healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Short term in vivo biocompatibility testing of biodegradable poly(D,L-lactide)--growth factor coating for orthopaedic implants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970014-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-1383(08)70014-7

1 reference

19 August 2017

1 reference

PubMed ID

18804572